Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.

Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.

Item
http://www.wikidata.org/entity/Q38428681
Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial.Botulinum toxin in the management of chronic migraine: clinical evidence and experience.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.Depression in blepharospasm: a question of facial feedback?Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures.Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study.Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.How the Experience of Emotion is Modulated by Facial Feedback.
P2860

Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.

Item
http://www.wikidata.org/entity/Q38428681
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Treatment of major depressive ...... ind, placebo-controlled study.
@en
type
label
Treatment of major depressive ...... ind, placebo-controlled study.
@en
prefLabel
Treatment of major depressive ...... ind, placebo-controlled study.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Treatment of major depressive ...... ind, placebo-controlled study.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921